A major 2026 trend in the US sector is the implementation of the new CMS "Per-Square-Centimeter" payment model. In 2026, the market is identifying "Economic Clinical Evidence" as a critical value-shifter for the Biological Skin Substitutes Market, as manufacturers must now prove their products save hospital systems money over an entire "episode of care." This 2026 movement is critical because...